<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800015735</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-04-17</date_registration>
      <primary_sponsor>Children's Hospital of Chongqing Medical University</primary_sponsor>
      <public_title>Safety of human umbilical cord derived mesenchymal stem cells (HU - MSCs) infusion treatment of children refractory lung diseases </public_title>
      <acronym />
      <scientific_title>Safety of human umbilical cord derived mesenchymal stem cells (HU - MSCs) infusion treatment of children refractory lung diseases</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2015-10-01</date_enrolment>
      <type_enrolment />
      <target_size>one cohort:10;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=24449</url>
      <study_type>Interventional study</study_type>
      <study_design>Cohort study</study_design>
      <phase>I (Phase I study)</phase>
      <hc_freetext>Children lung diseases</hc_freetext>
      <i_freetext>one cohort:mesenchymal stem cells infusion;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Xia yunqiu</firstname>
        <middlename />
        <lastname />
        <address>136 Second Zhongshan Road, Yuzhong District, Chongqing, China</address>
        <city />
        <country1 />
        <zip>400014</zip>
        <telephone>+86 13637719980</telephone>
        <email>xiayunqiu_0115@163.com</email>
        <affiliation>Children's Hospital of Chongqing Medical University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Fu zhou</firstname>
        <middlename />
        <lastname />
        <address>136 Second Zhongshan Road, Yuzhong District, Chongqing, China</address>
        <city />
        <country1 />
        <zip>400014</zip>
        <telephone>+86 13983021280</telephone>
        <email>fu_zhou79@126.com</email>
        <affiliation>Children's Hospital of Chongqing Medical University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. children refractory lung diseases;
2. cannot be healed by conventional drug therapy;
3. informed consent signed by parents and/or patients(&gt;14years old).</inclusion_criteria>
      <agemin>0.5</agemin>
      <agemax>12</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. complex congenital heart disease;
2. WHO class III or IV pulmonary hypertension;
3. congenital respiratory tract malformations;
4. congenital anomaly of nervous system;
5. hereditary diseases;
6. HIV infected/viral hepatitis/tuberculosis/ syphilis;
7. severe or uncontrolled infection not expected to survive 2 weeks;
8. active pneumorrhagia or tension pneumothorax;
9. malignant diseases;
10. patient participating or having participated in a clinical trial with another investigation drugs.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>safety;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>SpO2;liver and kidney functions;myocardial biochemical marker;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Chongqing Municipal Science and Technology Commission </source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-01-02</approval_date>
        <contact_name>Liu Enmei</contact_name>
        <contact_address>136 Second Zhongshan Road, Yuzhong District, Chongqing, China</contact_address>
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>